The story · written by opus-5.5,
France first allowed cannabis as a medicine in the form of an experiment. The trial began in March 2021. More than five years later it has ended without a permanent system to replace it, and the patients who were in it remain in a transition period that has been extended.
The legal basis
The experiment rests on Article 43 of the social security financing law for 2020, Law 2019-1446 of 24 December 2019, which authorised it for three years. A decree of 7 October 2020 and an order of 16 October 2020 set the rules and the specifications of the products.
Who could be treated
| Condition |
|---|
| Neuropathic pain that resists other treatments |
| Some forms of drug-resistant epilepsy |
| Some resistant symptoms of cancer or its treatment |
| Palliative care |
| Painful spasticity in multiple sclerosis or other diseases of the central nervous system |
How it worked
- The first prescription came from a doctor at one of the structures selected for the trial. Later a doctor chosen by the patient could take over, if trained.
- The medicine was dispensed by the unit’s pharmacy or by a town pharmacy that had agreed and trained its staff.
- A prescription covered 28 days at most.
- Two forms were allowed, both containing THC and CBD: dried flower for inhalation, and oral forms such as oil.
- Smoking was excluded from the protocol.
- The medicines were paid for by the health insurance system.
How it ended
| Date | Event |
|---|---|
| March 2021 | first patients enrolled |
| 27 March 2024 | no new patients admitted |
| 31 December 2024 | the experiment ends |
| 31 March 2026 | first end date of the transition period |
| after that | the transition is extended until three months after an opinion from the health authority that had not yet been published |
Patients already included keep their prescriptions during the transition. No date has been set for a general system. A decree on reimbursement followed in 2026.
Why the index moved
The index moved France from 13 to 14 with the 2021 experiment. Only access changed, from 0 to 1: a lawful supply existed for the first time, for a capped group of patients with five conditions. Nothing changed for anyone else, and use outside the trial stayed a criminal offence.[1]
Score by segment 0 to 10
- Possession · 25%1 → 1
- Personal cultivation · 25%1 → 1
- Punishment & enforcement · 20%3 → 3
- Sharing & gifting · 10%1 → 1
- Consumption · 10%1 → 1
- Legal access · 10%0 → 1+1
The bar shows the score after the change; the tick marks where it stood before. The scores after the change are France's current scores.
References
Checked. The date and the event were compared with a source that was read. The score before the change is an editorial estimate.